A recent study by Charles Darwin University and RMIT has uncovered promising results in the fight against melanoma using a cannabis extract. The research focused on cannabinoid PHEC-66, derived from the Cannabis sativa plant, which has shown efficacy in slowing melanoma cell growth and inducing cell death. This extract binds to specific receptor sites on melanoma cells, disrupting their growth and triggering apoptosis, or programmed cell death.

Dr. Nazim Nassar, a co-author of the study, emphasized the potential of cannabis extracts as anticancer agents, highlighting the need for advanced delivery systems to target melanoma cells effectively. The study, part of a PhD project by Dr. Ava Bachari, underscores the importance of understanding cannabis extracts’ interactions with cancer cells to refine treatment strategies.

The research, published in the journal Cells, marks a significant step towards developing cannabis-based cancer treatments. For more details, visit the Charles Darwin University news page.